Financhill
Back

Eagle Pharmaceuticals Quote, Financials, Valuation and Earnings

Eagle Pharmaceuticals Price Quote

$0.90
+0.25 (+37.99%)
(Updated: November 21, 2024 at 5:55 PM ET)

Eagle Pharmaceuticals Key Stats

Sell
14
Eagle Pharmaceuticals (EGRX) is a Sell

Day range:
$0.65 - $0.72
52-week range:
$0.00 - $9.10
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
3.1K
Avg. volume:
38.5K
1-year change:
-92.49%
Market cap:
$11.7M
Revenue:
$0
EPS:
$0.91

How Much Does Eagle Pharmaceuticals Make?

Is Eagle Pharmaceuticals Growing As A Company?

  • What Is Eagle Pharmaceuticals's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.13%
  • What Is Eagle Pharmaceuticals's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Eagle Pharmaceuticals Stock Price Performance

What Is Eagle Pharmaceuticals 52-Week High & Low?

Eagle Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Eagle Pharmaceuticals?

Is Eagle Pharmaceuticals Cash Flow Positive?

  • What Is EGRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.3M
  • What Is Eagle Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $11.9M
  • What Is Eagle Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$23.8M

Eagle Pharmaceuticals Return On Invested Capital

Data Unavailable

Eagle Pharmaceuticals Earnings Date & Stock Price

Eagle Pharmaceuticals Competitors

Eagle Pharmaceuticals Dividend Yield

Eagle Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 3.51%
Revenue: -12.8% 8.9%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 17.00
Upside from Last Price: 2506.56%

Major Shareholders

  • How many EGRX shares are owned by institutional investors?
    14.1M EGRX shares are owned by institutional investors
  • How many EGRX shares are owned by insiders?
    766.6K EGRX shares are owned by insiders